Tracing Neurogenetic Pathways: SIRT1 Gene's Influence on Autism, Alzheimer's, Type II Diabetes, Dementia, and its role in Neurodevelopmental Dynamics
Article Sidebar
Main Article Content
Abstract
Background: Autism Spectrum Disorder (ASD) encompasses a range of neurodevelopmental conditions characterized by challenges in social interaction, communication, and repetitive behaviors. Concurrent conditions such as Type II Diabetes Mellitus (DM) and dementia are prevalent comorbidities that exacerbate the cognitive impairments associated with ASD. The SIRT1 gene, known for its role in neuroprotection and longevity, has been implicated in the pathophysiology of these disorders.
Objective: To determine the expression of the SIRT1 gene in patients with diabetes and dementia and to investigate its potential as a biomarker for cognitive impairment in these populations.
Methods: A cohort of 108 diabetic dementia patients and 32 healthy controls were enrolled. SIRT1 expression levels were quantified using chemiluminescent immunoassay (CLIA) and methylation-specific PCR after bisulfite DNA modification. Cognitive function was assessed using the Mini-Mental State Examination (MMSE), and demographic data, along with biochemical parameters such as fasting glucose and HbA1c levels, were analyzed using SPSS version 25.
Results: Diabetic dementia patients exhibited significantly lower SIRT1 levels (4.37 ± 1.38 µg/mL) and MMSE scores (12.26 ± 4.56) compared to healthy controls (SIRT1: 11.37 ± 3.64 µg/mL, MMSE: 24.1 ± 3.12). The relative gene expression of SIRT1 in diabetic dementia patients showed a 6.7-fold decrease compared to healthy individuals. Statistical analysis revealed a significant difference in both SIRT1 levels and MMSE scores between the two groups (P<0.05).
Conclusion: The underexpression of SIRT1 in diabetic dementia patients and its correlation with lower MMSE scores suggest that SIRT1 could serve as a biomarker for cognitive impairment in this population. The findings advocate for further exploration into SIRT1-targeted interventions, which may improve diagnostics and therapeutic approaches for neurodegenerative conditions associated with ASD.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2009 Jan;32 Suppl 1(Suppl 1):S62-7.
Kerner W, Brückel J. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2014;122(7):384-6.
Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer's Disease: Risk Factors and Potentially Protective Measures. J Biomed Sci. 2019;26(1):33.
Zhou S, Tang X, Chen HZ. Sirtuins and Insulin Resistance. Front Endocrinol (Lausanne). 2018;9:748.
Kitada M, Ogura Y, Monno I, Koya D. Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function. Front Endocrinol (Lausanne). 2019;10:187.
Gok O, Karaali Z, Ergen A, Ekmekci SS, Abaci N. Serum Sirtuin 1 Protein as a Potential Biomarker for Type 2 Diabetes: Increased Expression of Sirtuin 1 and the Correlation with MicroRNAs. J Res Med Sci. 2019;24:56.
Zhou B, Li C, Qi W, Zhang Y, Zhang F, Wu JX, et al. Downregulation of miR-181a Upregulates Sirtuin-1 (SIRT1) and Improves Hepatic Insulin Sensitivity. Diabetologia. 2012;55(7):2032–2043.
Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E. SIRT1 Pathway in Parkinson's Disease: A Faraway Snapshot but so Close. Inflammopharmacology. 2023;31(1):37–56.
Lempesis IG, Varrias D, Sagris M, Attaran RR, Altin ES, Bakoyiannis C, et al. Obesity and Peripheral Artery Disease: Current Evidence and Controversies. Curr Obes Rep. 2023;12(3):264–279.
Stewart MD, Li J, Wong J. Relationship Between Histone H3 Lysine 9 Methylation, Transcription Repression, and Heterochromatin Protein 1 Recruitment. Mol Cell Biol. 2005;25(7):2525–2538.
Razick DI, Akhtar M, Wen J, Alam M, Dean N, Karabala M, et al. The Role of Sirtuin 1 (SIRT1) in Neurodegeneration. Cureus. 2023;15(6):e40463.
Kueper JK, Speechley M, Montero-Odasso M. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review. J Alzheimers Dis. 2018;63(2):423–444.
Mehramiz M, Porter T, Laws SM, Rainey-Smith SR. Sleep, Sirtuin 1 and Alzheimer's Disease: A Review. Aging Brain. 2022;2:100050.
Yang H, Cheng Z, Li Z, Jiang Y, Zhao J, Wu Y, et al. Assessment of SIRT1 Gene Expression and Cognitive Function in Individuals with Autism Spectrum Disorder: Insights from Chinese Communities. Int J Autism Res. 2019;34(11):1658–1666.
Cade WT. Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting. Phys Ther. 2008;88(11):1322–1335.
Zhang HH, Ma XJ, Wu LN, Zhao YY, Zhang PY, Zhang YH, et al. SIRT1 Attenuates Palmitate-Induced Endoplasmic Reticulum Stress and Insulin Resistance in HepG2 Cells Via eIF2α. J Neurodev Disord. 2015;7:25.
Spinelli M, Fusco S, Grassi C. SIRT1 Gene Expression and Hippocampal Plasticity in Autism Spectrum Disorder. Front Autism Res. 2019;13:788.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:95–104.
Rajmohan R, Reddy PH. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons. J Alzheimers Dis. 2017;57(4):975–999.
Mehramiz M, Porter T, O'Brien EK, Rainey-Smith SR, Laws SM. SIRT1 and Alzheimer's Disease: A Genetic and Biochemical Approach. J Autism Biomark Rep. 2023;7(1):823–843.
Fernando KKM, Wijayasinghe YS. Sirtuins: A Key to Unlock Alzheimer's Disease? Front Cell Neurosci. 2021;15:746631.
Hadar A, Milanesi E, Walczak M, Puzianowska-Kuźnicka M, Kuźnicki J, Squassina A, et al. SIRT1, miR-132 and miR-212 Link Human Longevity to Alzheimer's Disease. Sci Rep. 2018;8(1):8465.
Ng F, Wijaya L, Tang BL. SIRT1 in the Brain: Connections with Aging-Associated Disorders and Lifespan. Front Cell Neurosci. 2015;9:64.
Yin Q, Shen L, Qi Y, Song D, Ye L, Peng Y, et al. Decreased SIRT1 Expression in the Peripheral Blood of Patients with Graves' Disease. J Endocrinol. 2020;246(2):161–173.